nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—NGF—NF-kB is activated and signals survival—SQSTM1—age related macular degeneration	0.0822	0.0822	CbGpPWpGaD
Clenbuterol—NGF—p75NTR recruits signalling complexes—SQSTM1—age related macular degeneration	0.0822	0.0822	CbGpPWpGaD
Clenbuterol—NGF—NRIF signals cell death from the nucleus—SQSTM1—age related macular degeneration	0.0733	0.0733	CbGpPWpGaD
Clenbuterol—NGF—p75NTR signals via NF-kB—SQSTM1—age related macular degeneration	0.0697	0.0697	CbGpPWpGaD
Clenbuterol—NGF—SIDS Susceptibility Pathways—REST—age related macular degeneration	0.0395	0.0395	CbGpPWpGaD
Clenbuterol—TNF—Matrix Metalloproteinases—TIMP3—age related macular degeneration	0.0346	0.0346	CbGpPWpGaD
Clenbuterol—ADRB1—Melatonin metabolism and effects—MAP2—age related macular degeneration	0.0268	0.0268	CbGpPWpGaD
Clenbuterol—NGF—Cell death signalling via NRAGE, NRIF and NADE—SQSTM1—age related macular degeneration	0.0239	0.0239	CbGpPWpGaD
Clenbuterol—NGF—Neurotrophic factor-mediated Trk receptor signaling—SQSTM1—age related macular degeneration	0.0239	0.0239	CbGpPWpGaD
Clenbuterol—NGF—SIDS Susceptibility Pathways—MAP2—age related macular degeneration	0.0227	0.0227	CbGpPWpGaD
Clenbuterol—NGF—p75(NTR)-mediated signaling—SQSTM1—age related macular degeneration	0.0216	0.0216	CbGpPWpGaD
Clenbuterol—NGF—p75 NTR receptor-mediated signalling—SQSTM1—age related macular degeneration	0.0188	0.0188	CbGpPWpGaD
Clenbuterol—CYP1A1—Melatonin metabolism and effects—MAP2—age related macular degeneration	0.0174	0.0174	CbGpPWpGaD
Clenbuterol—TNF—Caspase Cascade in Apoptosis—TNFRSF10A—age related macular degeneration	0.0157	0.0157	CbGpPWpGaD
Clenbuterol—TNF—Amyotrophic lateral sclerosis (ALS)—CST3—age related macular degeneration	0.0156	0.0156	CbGpPWpGaD
Clenbuterol—NGF—SHP2 signaling—KDR—age related macular degeneration	0.0144	0.0144	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—REST—age related macular degeneration	0.0144	0.0144	CbGpPWpGaD
Clenbuterol—TNF—Overview of nanoparticle effects—CRP—age related macular degeneration	0.0134	0.0134	CbGpPWpGaD
Clenbuterol—NGF—BDNF signaling pathway—SQSTM1—age related macular degeneration	0.012	0.012	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—TGFBR1—age related macular degeneration	0.0117	0.0117	CbGpPWpGaD
Clenbuterol—CYP1A2—Melatonin metabolism and effects—MAP2—age related macular degeneration	0.0111	0.0111	CbGpPWpGaD
Clenbuterol—TNF—TNF receptor signaling pathway —SQSTM1—age related macular degeneration	0.0109	0.0109	CbGpPWpGaD
Clenbuterol—TNF—TGF-beta Receptor Signaling—TGFBR1—age related macular degeneration	0.0106	0.0106	CbGpPWpGaD
Clenbuterol—TNF—Cardiac Hypertrophic Response—TGFBR1—age related macular degeneration	0.0104	0.0104	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—SQSTM1—age related macular degeneration	0.00973	0.00973	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—MAP2—age related macular degeneration	0.00826	0.00826	CbGpPWpGaD
Clenbuterol—NGF—SHP2 signaling—VEGFA—age related macular degeneration	0.00794	0.00794	CbGpPWpGaD
Clenbuterol—ADRB1—Melatonin metabolism and effects—APOE—age related macular degeneration	0.00786	0.00786	CbGpPWpGaD
Clenbuterol—ADRB3—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.00766	0.00766	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.00731	0.00731	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—SQSTM1—age related macular degeneration	0.00694	0.00694	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.00656	0.00656	CbGpPWpGaD
Clenbuterol—TNF—IL23-mediated signaling events—CCL2—age related macular degeneration	0.00645	0.00645	CbGpPWpGaD
Clenbuterol—TNF—Vitamin B12 Metabolism—CRP—age related macular degeneration	0.00606	0.00606	CbGpPWpGaD
Clenbuterol—TNF—Vitamin B12 Metabolism—APOE—age related macular degeneration	0.00593	0.00593	CbGpPWpGaD
Clenbuterol—TNF—TWEAK Signaling Pathway—CCL2—age related macular degeneration	0.00583	0.00583	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—APOE—age related macular degeneration	0.00575	0.00575	CbGpPWpGaD
Clenbuterol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ELOVL4—age related macular degeneration	0.00563	0.00563	CbGpPWpGaD
Clenbuterol—CYP1A1—Melatonin metabolism and effects—APOE—age related macular degeneration	0.00512	0.00512	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—RHO—age related macular degeneration	0.005	0.005	CbGpPWpGaD
Clenbuterol—TNF—Vitamin B12 Metabolism—CCL2—age related macular degeneration	0.00499	0.00499	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—CRP—age related macular degeneration	0.00493	0.00493	CbGpPWpGaD
Clenbuterol—TNF—Transcriptional regulation of white adipocyte differentiation—CD36—age related macular degeneration	0.00484	0.00484	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—RDH8—age related macular degeneration	0.00478	0.00478	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.00455	0.00455	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—SQSTM1—age related macular degeneration	0.0045	0.0045	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—C3—age related macular degeneration	0.00449	0.00449	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.00445	0.00445	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.00429	0.00429	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—TGFBR1—age related macular degeneration	0.00426	0.00426	CbGpPWpGaD
Clenbuterol—TNF—Alzheimers Disease—APOE—age related macular degeneration	0.00418	0.00418	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—RPE65—age related macular degeneration	0.00417	0.00417	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—CCL2—age related macular degeneration	0.00406	0.00406	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.00401	0.00401	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00392	0.00392	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.00389	0.00389	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00385	0.00385	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.00381	0.00381	CbGpPWpGaD
Clenbuterol—NGF—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.0036	0.0036	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00348	0.00348	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—ABCA4—age related macular degeneration	0.00337	0.00337	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—TLR4—age related macular degeneration	0.00334	0.00334	CbGpPWpGaD
Clenbuterol—CYP1A2—Melatonin metabolism and effects—APOE—age related macular degeneration	0.00326	0.00326	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00322	0.00322	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—CCL2—age related macular degeneration	0.00311	0.00311	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—TLR4—age related macular degeneration	0.00297	0.00297	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—RHO—age related macular degeneration	0.00297	0.00297	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—RHO—age related macular degeneration	0.00293	0.00293	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—RHO—age related macular degeneration	0.0029	0.0029	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—RHO—age related macular degeneration	0.00282	0.00282	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—TLR4—age related macular degeneration	0.00261	0.00261	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—RHO—age related macular degeneration	0.00256	0.00256	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.00256	0.00256	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—CCL2—age related macular degeneration	0.00255	0.00255	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RDH8—age related macular degeneration	0.00247	0.00247	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—VEGFA—age related macular degeneration	0.00226	0.00226	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00224	0.00224	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RPE65—age related macular degeneration	0.00216	0.00216	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00212	0.00212	CbGpPWpGaD
Clenbuterol—CYP1A1—PPARA activates gene expression—CD36—age related macular degeneration	0.002	0.002	CbGpPWpGaD
Clenbuterol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—age related macular degeneration	0.00195	0.00195	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00191	0.00191	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ABCA4—age related macular degeneration	0.00174	0.00174	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—RHO—age related macular degeneration	0.00168	0.00168	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00166	0.00166	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TGFBR1—age related macular degeneration	0.00164	0.00164	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—RHO—age related macular degeneration	0.00164	0.00164	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—C3—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—RHO—age related macular degeneration	0.00152	0.00152	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RHO—age related macular degeneration	0.00151	0.00151	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—SQSTM1—age related macular degeneration	0.00149	0.00149	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—RHO—age related macular degeneration	0.00149	0.00149	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RDH8—age related macular degeneration	0.00147	0.00147	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RDH8—age related macular degeneration	0.00143	0.00143	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00143	0.00143	CbGpPWpGaD
Clenbuterol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00131	0.00131	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RPE65—age related macular degeneration	0.00128	0.00128	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CCL2—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RPE65—age related macular degeneration	0.00125	0.00125	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00123	0.00123	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00122	0.00122	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NMNAT1—age related macular degeneration	0.00114	0.00114	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—CD36—age related macular degeneration	0.00109	0.00109	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ABCA4—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ABCA4—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ELOVL4—age related macular degeneration	0.000998	0.000998	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.000985	0.000985	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.000964	0.000964	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—C3—age related macular degeneration	0.000959	0.000959	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—C3—age related macular degeneration	0.000947	0.000947	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—KDR—age related macular degeneration	0.000945	0.000945	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—C3—age related macular degeneration	0.000938	0.000938	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000925	0.000925	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—C3—age related macular degeneration	0.000913	0.000913	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RHO—age related macular degeneration	0.000899	0.000899	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000892	0.000892	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—APOE—age related macular degeneration	0.000881	0.000881	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RHO—age related macular degeneration	0.000879	0.000879	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—KDR—age related macular degeneration	0.000863	0.000863	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TGFBR1—age related macular degeneration	0.00085	0.00085	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—C3—age related macular degeneration	0.000829	0.000829	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—SLC16A8—age related macular degeneration	0.000804	0.000804	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SQSTM1—age related macular degeneration	0.000771	0.000771	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CCL2—age related macular degeneration	0.00075	0.00075	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCL2—age related macular degeneration	0.000741	0.000741	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CCL2—age related macular degeneration	0.000734	0.000734	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NMNAT1—age related macular degeneration	0.000728	0.000728	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CCL2—age related macular degeneration	0.000649	0.000649	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ELOVL4—age related macular degeneration	0.000636	0.000636	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00059	0.00059	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000569	0.000569	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—C3—age related macular degeneration	0.000542	0.000542	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000536	0.000536	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—C3—age related macular degeneration	0.00053	0.00053	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—VEGFA—age related macular degeneration	0.000521	0.000521	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—SLC16A8—age related macular degeneration	0.000513	0.000513	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000505	0.000505	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000494	0.000494	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—C3—age related macular degeneration	0.000492	0.000492	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—C3—age related macular degeneration	0.00049	0.00049	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—C3—age related macular degeneration	0.000481	0.000481	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—VEGFA—age related macular degeneration	0.000476	0.000476	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000473	0.000473	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000458	0.000458	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—APOE—age related macular degeneration	0.000456	0.000456	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SQSTM1—age related macular degeneration	0.000448	0.000448	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—KDR—age related macular degeneration	0.000447	0.000447	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—LIPC—age related macular degeneration	0.000412	0.000412	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CETP—age related macular degeneration	0.000397	0.000397	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCL2—age related macular degeneration	0.000385	0.000385	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCL2—age related macular degeneration	0.000383	0.000383	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCL2—age related macular degeneration	0.000377	0.000377	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000342	0.000342	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000302	0.000302	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—C3—age related macular degeneration	0.000291	0.000291	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—C3—age related macular degeneration	0.000284	0.000284	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—APOE—age related macular degeneration	0.000271	0.000271	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KDR—age related macular degeneration	0.000265	0.000265	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—APOE—age related macular degeneration	0.000265	0.000265	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—LIPC—age related macular degeneration	0.000263	0.000263	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KDR—age related macular degeneration	0.000259	0.000259	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CETP—age related macular degeneration	0.000253	0.000253	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—VEGFA—age related macular degeneration	0.000246	0.000246	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CD36—age related macular degeneration	0.000239	0.000239	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCL2—age related macular degeneration	0.000227	0.000227	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCL2—age related macular degeneration	0.000222	0.000222	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—APOE—age related macular degeneration	0.000211	0.000211	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CD36—age related macular degeneration	0.000152	0.000152	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—VEGFA—age related macular degeneration	0.000146	0.000146	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—VEGFA—age related macular degeneration	0.000143	0.000143	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—APOE—age related macular degeneration	0.000134	0.000134	CbGpPWpGaD
